8-K · 2026-11-05
Cogent Biosciences, Inc. announces its Q3 2026 financial results, showcasing advancements in its pharmaceutical pipeline.
| Name | Cogent Biosciences, Inc. |
|---|---|
| CIK | 0001622229 |
| Tickers | COGT |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 465308248 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | 617-945-5576 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Cogent Biosciences, Inc. announces its Q3 2026 financial results, showcasing advancements in its pharmaceutical pipeline.
616 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-05 | 10-Q | 10-Q | 0001193125-26-449963 | 001-38443 | 261527836 | 34 | 9527627 | 1 | 1 | |
| 2026-11-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-449926 | 001-38443 | 261527714 | 34 | 628635 | 1 | 1 |
| 2026-10-05 | 4 | 4 | 0001193125-26-414218 | 5777 | ||||||
| 2026-09-02 | 8-K | 8-K | 1.01 | 0001193125-26-380194 | 001-38443 | 261354876 | 34 | 138623 | 1 | 1 |
| 2026-08-31 | 4 | 4 | 0001193125-26-377001 | 14207 | ||||||
| 2026-08-27 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008754 | 001-38443 | 261330521 | 33 | 4965 | |||
| 2026-08-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193805-26-001082 | 005-90431 | 261273383 | 34 | 17258 | |||
| 2026-08-10 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-342695 | 001-38443 | 261259577 | 34 | 155391 | 1 | 1 |
| 2026-08-10 | 424B5 | 424B5 | 0001193125-26-342683 | 333-291384 | 261259556 | 33 | 577993 | 1 | 1 | |
| 2026-08-10 | 10-Q | 10-Q | 0001193125-26-342393 | 001-38443 | 261258522 | 34 | 8482967 | 1 | 1 | |
| 2026-08-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-341315 | 001-38443 | 261256318 | 34 | 375741 | 1 | 1 |
| 2026-07-31 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-001323 | 005-90431 | 261225840 | 34 | 7606 | |||
| 2026-07-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002235 | 005-90431 | 261206128 | 34 | 11294 | |||
| 2026-07-06 | 4 | 4 | 0001193125-26-296249 | 5777 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267665 | 6159 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267663 | 5564 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267662 | 6156 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267670 | 5583 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267667 | 5575 | ||||||
| 2026-06-11 | 4 | 4 | 0001193125-26-267666 | 5575 | ||||||
| 2026-06-11 | 8-K | 8-K | 5.07 | 0001193125-26-267566 | 001-38443 | 261083203 | 34 | 149510 | 1 | 1 |
| 2026-05-21 | 4 | 4 | 0001193125-26-234578 | 6495 | ||||||
| 2026-05-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193805-26-000609 | 005-90431 | 26981098 | 34 | 17047 | |||
| 2026-05-05 | 10-Q | 10-Q | 0001193125-26-205170 | 001-38443 | 26940565 | 34 | 7420600 | 1 | 1 | |
| 2026-05-05 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-205124 | 001-38443 | 26940535 | 34 | 345603 | 1 | 1 |
| 2026-04-23 | ARS | ARS | 0001193125-26-173857 | 001-38443 | 26889194 | 34 | 1090316 | |||
| 2026-04-23 | DEFA14A | DEFA14A | 0001193125-26-173848 | 001-38443 | 26889162 | 34 | 814007 | |||
| 2026-04-23 | DEF 14A | DEF 14A | 0001193125-26-173834 | 001-38443 | 26889121 | 34 | 2654231 | 1 | 1 | |
| 2026-04-03 | 4 | 4 | 0001193125-26-142082 | 5867 | ||||||
| 2026-03-31 | 144 | xsl144X01/primary_doc.xml | 0001104659-26-038058 | 001-38443 | 26824376 | 33 | 5714 | |||
| 2026-03-31 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-038057 | 11018 | ||||||
| 2026-03-31 | SCHEDULE 13D/A | xslSCHEDULE_13D_X02/primary_doc.xml | 0001104659-26-038056 | 005-90431 | 26824373 | 34 | 11827 | |||
| 2026-03-26 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-000905 | 005-90431 | 26799310 | 34 | 7374 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001831942-26-000011 | 005-90431 | 26642707 | 34 | 15667 | |||
| 2026-02-17 | S-8 | S-8 | 0001193125-26-054555 | 333-293512 | 26640773 | 33 | 208559 | 1 | 1 | |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001907884-26-000002 | 005-90431 | 26638889 | 34 | 9523 | |||
| 2026-02-17 | 10-K | 10-K | 0001193125-26-053334 | 001-38443 | 26637138 | 34 | 16020615 | 1 | 1 | |
| 2026-02-17 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-053131 | 001-38443 | 26636581 | 34 | 406288 | 1 | 1 |
| 2026-01-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000102909-26-000056 | 005-90431 | 26581869 | 34 | 7216 | |||
| 2026-01-22 | 4 | OWNERSHIP DOCUMENT | 0001104659-26-005924 | 8033 | ||||||
| 2026-01-22 | 144 | xsl144X01/primary_doc.xml | 0001104659-26-005919 | 001-38443 | 26552991 | 33 | 6102 | |||
| 2026-01-22 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001104659-26-005917 | 005-90431 | 26552989 | 34 | 11717 | |||
| 2026-01-21 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-26-000802 | 005-90431 | 26547563 | 34 | 11423 | |||
| 2026-01-21 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-26-000657 | 005-90431 | 26545840 | 34 | 11234 | |||
| 2026-01-05 | 4 | 4 | 0001193125-26-002367 | 5672 | ||||||
| 2025-12-30 | 4 | 4 | 0001193125-25-337052 | 5341 | ||||||
| 2025-12-30 | 4 | 4 | 0001193125-25-337051 | 5380 | ||||||
| 2025-12-30 | 4 | 4 | 0001193125-25-337050 | 5366 | ||||||
| 2025-12-30 | 4 | 4 | 0001193125-25-337049 | 5397 | ||||||
| 2025-12-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-010709 | 001-38443 | 251604242 | 33 | 8641 | |||
| 2025-12-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-010708 | 001-38443 | 251603887 | 33 | 5712 | |||
| 2025-12-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-010706 | 001-38443 | 251603866 | 33 | 5102 | |||
| 2025-12-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-010704 | 001-38443 | 251603839 | 33 | 5095 | |||
| 2025-12-19 | 4 | 4 | 0001193125-25-326776 | 10830 | ||||||
| 2025-12-19 | 4 | 4 | 0001193125-25-326775 | 10849 | ||||||
| 2025-12-19 | 4 | 4 | 0001193125-25-326774 | 11037 | ||||||
| 2025-12-19 | 4 | 4 | 0001193125-25-326772 | 10774 | ||||||
| 2025-12-19 | 4 | 4 | 0001193125-25-326773 | 10799 | ||||||
| 2025-12-19 | 4 | 4 | 0001193125-25-326771 | 10813 | ||||||
| 2025-12-08 | 8-K | 8-K | 8.01 | 0001193125-25-311217 | 001-38443 | 251556134 | 34 | 168912 | 1 | 1 |
| 2025-11-18 | 8-K | 8-K | 1.01,2.03,9.01 | 0001193125-25-286158 | 001-38443 | 251494707 | 34 | 1201731 | 1 | 1 |
| 2025-11-17 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001104659-25-113219 | 005-90431 | 251491508 | 34 | 21051 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001831942-25-000029 | 005-90431 | 251487832 | 34 | 15777 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-112634 | 005-90431 | 251487304 | 34 | 12618 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193125-25-283076 | 005-90431 | 251486880 | 34 | 13169 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-005033 | 005-90431 | 251486551 | 34 | 13304 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001907884-25-000004 | 005-90431 | 251483616 | 34 | 9601 | |||
| 2025-11-13 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-25-278679 | 001-38443 | 251475196 | 34 | 674967 | 1 | 1 |
| 2025-11-12 | 424B5 | 424B5 | 0001193125-25-277586 | 333-291384 | 251472821 | 33 | 687607 | 1 | 1 | |
| 2025-11-12 | 424B5 | 424B5 | 0001193125-25-277503 | 333-291384 | 251472504 | 33 | 1362209 | 1 | 1 | |
| 2025-11-12 | FWP | FWP | 0001193125-25-275686 | 333-291384 | 251468333 | 34 | 56857 | |||
| 2025-11-12 | 424B5 | 424B5 | 0001193125-25-274642 | 333-291384 | 251467599 | 33 | 546248 | |||
| 2025-11-12 | 424B5 | 424B5 | 0001193125-25-274621 | 333-291384 | 251467551 | 33 | 1209523 | |||
| 2025-11-10 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-273315 | 001-38443 | 251464430 | 34 | 9060113 | 1 | 1 |
| 2025-11-07 | S-3ASR | S-3ASR | 0001193125-25-272499 | 333-291384 | 251463278 | 33 | 1170270 | 1 | 1 | |
| 2025-11-07 | 10-Q | 10-Q | 0001193125-25-272334 | 001-38443 | 251462700 | 34 | 9726974 | 1 | 1 | |
| 2025-11-03 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-261797 | 001-38443 | 251442344 | 34 | 605648 | 1 | 1 |
| 2025-10-03 | 4 | 4 | 0001193125-25-230215 | 5673 | ||||||
| 2025-09-11 | 8-K | 8-K | 1.01,2.03,9.01 | 0001193125-25-201353 | 001-38443 | 251308899 | 34 | 685618 | 1 | 1 |
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-022022 | 005-90431 | 251221523 | 34 | 22421 | |||
| 2025-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001831942-25-000016 | 005-90431 | 251220855 | 34 | 16067 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001831942-25-000009 | 005-90431 | 251220801 | 34 | 12353 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-078669 | 005-90431 | 251219988 | 34 | 12631 | |||
| 2025-08-05 | 10-Q | 10-Q | 0000950170-25-102440 | 001-38443 | 251182992 | 34 | 10408560 | 1 | 1 | |
| 2025-08-05 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-102433 | 001-38443 | 251182973 | 34 | 603974 | 1 | 1 |
| 2025-07-14 | SCHEDULE 13D/A | xslSCHEDULE_13D_X01/primary_doc.xml | 0001104659-25-067760 | 005-90431 | 251122052 | 34 | 17398 | |||
| 2025-07-14 | 4 | OWNERSHIP DOCUMENT | 0001104659-25-067758 | 5949 | ||||||
| 2025-07-11 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193805-25-001001 | 005-90431 | 251117560 | 34 | 16885 | |||
| 2025-07-10 | 8-K | 8-K | 1.01,2.02,9.01 | 0001193125-25-157390 | 001-38443 | 251114855 | 34 | 424246 | 1 | 1 |
| 2025-07-09 | 424B5 | 424B5 | 0001193125-25-157121 | 333-269707 | 251114050 | 33 | 754576 | 1 | 1 | |
| 2025-07-08 | 424B5 | 424B5 | 0001193125-25-156654 | 333-269707 | 251111695 | 33 | 607234 | |||
| 2025-07-07 | 8-K | 8-K | 8.01 | 0001193125-25-155811 | 001-38443 | 251106969 | 34 | 151112 | 1 | 1 |
| 2025-07-02 | 4 | 4 | 0000950170-25-092976 | 5675 | ||||||
| 2025-06-11 | 8-K | 8-K | 1.01,2.03,7.01,9.01 | 0001193125-25-138813 | 001-38443 | 251038824 | 34 | 165893 | 1 | 1 |
| 2025-06-05 | 4 | 4 | 0000950170-25-082374 | 5371 | ||||||
| 2025-06-05 | 4 | 4 | 0000950170-25-082368 | 5964 | ||||||
| 2025-06-05 | 4 | 4 | 0000950170-25-082365 | 5382 | ||||||
| 2025-06-05 | 4 | 4 | 0000950170-25-082364 | 5390 | ||||||
| 2025-06-05 | 4 | 4 | 0000950170-25-082349 | 5967 | ||||||
| 2025-06-05 | 4 | 4 | 0000950170-25-082348 | 5382 | ||||||
| 2025-06-05 | 8-K | 8-K | 5.03,5.07,7.01,9.01 | 0001193125-25-135337 | 001-38443 | 251025066 | 34 | 6326199 | 1 | 1 |
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-049526 | 005-90431 | 25954446 | 34 | 12541 | |||
| 2025-05-09 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-001478 | 333-264773 | 25932349 | 33 | 1959 | ||
| 2025-05-06 | 10-Q | 10-Q | 0000950170-25-064005 | 001-38443 | 25915571 | 34 | 7154965 | 1 | 1 | |
| 2025-05-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-063987 | 001-38443 | 25915370 | 34 | 612764 | 1 | 1 |
| 2025-05-06 | 424B5 | 424B5 | 0001193125-25-113402 | 333-269707 | 25915334 | 33 | 756703 | 1 | 1 | |
| 2025-05-06 | POS AM | POS AM | 0001193125-25-113367 | 333-264773 | 25915321 | 33 | 19804 | |||
| 2025-04-22 | ARS | ARS | 0001193125-25-089258 | 001-38443 | 25858216 | 34 | 6375274 | |||
| 2025-04-22 | DEFA14A | DEFA14A | 0001193125-25-089248 | 001-38443 | 25858178 | 34 | 143309 | |||
| 2025-04-22 | DEF 14A | DEF 14A | 0001193125-25-089237 | 001-38443 | 25858127 | 34 | 2558695 | 1 | 1 | |
| 2025-04-11 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001415889-25-010591 | 005-90431 | 25833839 | 34 | 25370 | |||
| 2025-04-11 | PRE 14A | PRE 14A | 0001193125-25-079139 | 001-38443 | 25832469 | 34 | 2573167 | 1 | 1 | |
| 2025-04-03 | 4 | 4 | 0000950170-25-050374 | 5729 | ||||||
| 2025-02-25 | S-8 | S-8 | 0001193125-25-035115 | 333-285198 | 25662911 | 33 | 262722 | 1 | 1 | |
| 2025-02-25 | 10-K | 10-K | 0000950170-25-026115 | 001-38443 | 25659567 | 34 | 22699119 | 1 | 1 | |
| 2025-02-25 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-026103 | 001-38443 | 25659519 | 34 | 647865 | 1 | 1 |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-001038 | 005-90431 | 25628647 | 34 | 13573 | |||
| 2025-02-12 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-012215 | 005-90431 | 25615399 | 34 | 16448 | |||
| 2025-02-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-25-000872 | 005-90431 | 25612538 | 34 | 11737 | |||
| 2025-01-27 | 4 | 4 | 0000950170-25-009271 | 5412 | ||||||
| 2025-01-27 | 4 | 4 | 0000950170-25-009266 | 5400 | ||||||
| 2025-01-27 | 4 | 4 | 0000950170-25-009263 | 5429 | ||||||
| 2025-01-27 | 4 | 4 | 0000950170-25-009258 | 5398 | ||||||
| 2025-01-27 | 4 | 4 | 0000950170-25-009257 | 5442 | ||||||
| 2025-01-27 | 4 | 4 | 0000950170-25-009256 | 5373 | ||||||
| 2025-01-15 | 4 | 4 | 0000950170-25-005630 | 5348 | ||||||
| 2025-01-03 | 4 | 4 | 0000950170-25-001210 | 5677 | ||||||
| 2024-12-09 | 8-K | 8-K | 8.01 | 0001193125-24-273393 | 001-38443 | 241535035 | 34 | 174470 | 1 | 1 |
| 2024-11-14 | SC 13G/A | COGENT BIOSCIENCES, INC. | 0000902664-24-006674 | 005-90431 | 241465345 | 34 | 78746 | |||
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-119314 | 005-90431 | 241464754 | 34 | 238752 | |||
| 2024-11-14 | SC 13G/A | formsc13ga.htm | 0001493152-24-045813 | 005-90431 | 241461817 | 34 | 90499 | |||
| 2024-11-14 | SC 13G/A | d11522645_13g-a.htm | 0000919574-24-006725 | 005-90431 | 241461249 | 34 | 119402 | |||
| 2024-11-14 | SC 13G/A | KYNAM CAPITAL MANAGEMENT, LP | 0001085146-24-005824 | 005-90431 | 241459348 | 34 | 44401 | |||
| 2024-11-12 | 10-Q | 10-Q | 0000950170-24-124712 | 001-38443 | 241444004 | 34 | 6331300 | 1 | 1 | |
| 2024-11-12 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-124653 | 001-38443 | 241443724 | 34 | 422304 | 1 | 1 |
| 2024-11-07 | SC 13G/A | filing.txt | 0000315066-24-002596 | 005-90431 | 241433521 | 34 | 8434 | |||
| 2024-11-07 | SC 13G/A | filing.txt | 0000315066-24-002573 | 005-90431 | 241433471 | 34 | 8426 | |||
| 2024-10-02 | 4 | 4 | 0000950170-24-111468 | 5683 | ||||||
| 2024-09-03 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-211584 | 001-38443 | 241272088 | 34 | 168020 | 1 | 1 |
| 2024-08-06 | S-8 | S-8 | 0001193125-24-194929 | 333-281291 | 241180203 | 33 | 297917 | 1 | 1 | |
| 2024-08-06 | 10-Q | 10-Q | 0000950170-24-091229 | 001-38443 | 241177242 | 34 | 7099292 | 1 | 1 | |
| 2024-08-06 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-091220 | 001-38443 | 241177206 | 34 | 422278 | 1 | 1 |
| 2024-07-02 | 4 | 4 | 0000950170-24-080555 | 5682 | ||||||
| 2024-06-27 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-169756 | 001-38443 | 241075411 | 34 | 164105 | 1 | 1 |
| 2024-06-13 | 4 | 4 | 0000950170-24-073238 | 5974 | ||||||
| 2024-06-13 | 4 | 4 | 0000950170-24-073235 | 5392 | ||||||
| 2024-06-13 | 4 | 4 | 0000950170-24-073234 | 5381 | ||||||
| 2024-06-13 | 4 | 4 | 0000950170-24-073231 | 5977 | ||||||
| 2024-06-13 | 4 | 4 | 0000950170-24-073228 | 5400 | ||||||
| 2024-06-13 | 4 | 4 | 0000950170-24-073226 | 5392 | ||||||
| 2024-06-13 | SC 13D/A | SC 13D/A | 0001193125-24-160264 | 005-90431 | 241039944 | 34 | 53288 | |||
| 2024-06-12 | 4 | 4 | 0000950170-24-072639 | 9395 | ||||||
| 2024-06-05 | 8-K | 8-K | 5.03,5.07,9.01 | 0001193125-24-155116 | 001-38443 | 241021924 | 34 | 177528 | 1 | 1 |
| 2024-05-29 | 4 | 4 | 0000950170-24-065900 | 5537 | ||||||
| 2024-05-29 | 3 | 3 | 0000950170-24-065891 | 14357 | ||||||
| 2024-05-07 | 10-Q | 10-Q | 0000950170-24-053977 | 001-38443 | 24919748 | 34 | 6346723 | 1 | 1 | |
| 2024-05-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-053974 | 001-38443 | 24919737 | 34 | 382107 | 1 | 1 |
| 2024-04-23 | ARS | ARS | 0001193125-24-107137 | 001-38443 | 24865339 | 34 | 3637548 | |||
| 2024-04-23 | DEFA14A | DEFA14A | 0001193125-24-107128 | 001-38443 | 24865298 | 34 | 142689 | |||
| 2024-04-23 | DEF 14A | DEF 14A | 0001193125-24-107124 | 001-38443 | 24865267 | 34 | 728179 | |||
| 2024-04-12 | PRE 14A | PRE 14A | 0001193125-24-094760 | 001-38443 | 24841917 | 34 | 728636 | |||
| 2024-04-10 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2024-04-10 16:00:00 | 9999999995-24-000926 | 333-278382 | 24837025 | 33 | 1953 | ||
| 2024-04-08 | CORRESP | filename1.htm | 0001193125-24-089670 | 7105 | ||||||
| 2024-04-05 | UPLOAD | filename1.pdf | 0000000000-24-003700 | 333-278382 | 40480 | |||||
| 2024-04-02 | 4 | 4 | 0000950170-24-040496 | 5681 | ||||||
| 2024-04-01 | SC 13D/A | SC 13D/A | 0001193125-24-083703 | 005-90431 | 24811557 | 34 | 72840 | |||
| 2024-04-01 | 4 | 4 | 0000950170-24-039588 | 13115 | ||||||
| 2024-03-29 | S-3 | S-3 | 0001193125-24-082065 | 333-278382 | 24804218 | 33 | 382076 | |||
| 2024-03-27 | SC 13D/A | SC 13D/A | 0001193125-24-078864 | 005-90431 | 24791393 | 34 | 73559 | |||
| 2024-03-22 | 8-K | 8-K | 3.02,5.03,9.01 | 0001193125-24-074628 | 001-38443 | 24773194 | 34 | 224854 | 1 | 1 |
| 2024-02-26 | S-8 | S-8 | 0001193125-24-046239 | 333-277360 | 24679488 | 33 | 69104 | |||
| 2024-02-26 | 10-K | 10-K | 0000950170-24-019770 | 001-38443 | 24673813 | 34 | 16851214 | 1 | 1 | |
| 2024-02-26 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-019754 | 001-38443 | 24673653 | 34 | 431043 | 1 | 1 |
| 2024-02-16 | SC 13D/A | SC 13D/A | 0001193125-24-038694 | 005-90431 | 24650069 | 34 | 78497 | |||
| 2024-02-16 | 4 | 4 | 0000950170-24-016610 | 9962 | ||||||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-024207 | 005-90431 | 24641660 | 34 | 258436 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023987 | 005-90431 | 24640138 | 34 | 81662 | |||
| 2024-02-14 | SC 13G/A | COGENT BIOSCIENCES, INC. | 0000902664-24-001689 | 005-90431 | 24638208 | 34 | 81898 | |||
| 2024-02-14 | SC 13G/A | formsc13ga.htm | 0001493152-24-006621 | 005-90431 | 24637788 | 34 | 90535 | |||
| 2024-02-14 | SC 13G | KYNAM CAPITAL MANAGEMENT, LP | 0001085146-24-001356 | 005-90431 | 24635189 | 34 | 44330 | |||
| 2024-02-14 | 8-K | 8-K | 1.01,3.02,5.03,7.01,9.01 | 0001193125-24-035203 | 001-38443 | 24632603 | 34 | 912862 | 1 | 1 |
| 2024-02-13 | SC 13G | SCHEDULE 13G | 0001104659-24-020637 | 005-90431 | 24627835 | 34 | 13217 | |||
| 2024-02-09 | SC 13G/A | SC 13G/A | 0001193125-24-030060 | 005-90431 | 24615335 | 34 | 57418 | |||
| 2024-02-09 | SC 13G | filing.txt | 0000315066-24-001074 | 005-90431 | 24611529 | 34 | 8360 | |||
| 2024-02-05 | SC 13G | d10938931_13-g.htm | 0000919574-24-000675 | 005-90431 | 24596413 | 34 | 121156 | |||
| 2024-01-26 | SC 13G/A | us19240q2012_012624.txt | 0001086364-24-004363 | 005-90431 | 24565873 | 34 | 13751 | |||
| 2024-01-25 | 4 | 4 | 0000950170-24-007436 | 5432 | ||||||
| 2024-01-25 | 4 | 4 | 0000950170-24-007422 | 5376 | ||||||
| 2024-01-25 | 4 | 4 | 0000950170-24-007415 | 5401 | ||||||
| 2024-01-25 | 4 | 4 | 0000950170-24-007414 | 5448 | ||||||
| 2024-01-25 | 4 | 4 | 0000950170-24-007410 | 5415 | ||||||
| 2024-01-23 | SC 13G/A | Cogent_Bio_Inc.txt | 0000093751-24-000073 | 005-90431 | 24550578 | 34 | 8655 | |||
| 2024-01-04 | 4 | 4 | 0000950170-24-001886 | 5681 | ||||||
| 2024-01-04 | 4 | 4 | 0000950170-24-001876 | 5692 | ||||||
| 2023-12-11 | 8-K | 8-K | 8.01 | 0001193125-23-292084 | 001-38443 | 231476963 | 34 | 184489 | 1 | 1 |
| 2023-11-07 | 10-Q | 10-Q | 0000950170-23-059769 | 001-38443 | 231381562 | 34 | 6877069 | 1 | 1 | |
| 2023-11-02 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-057785 | 001-38443 | 231370371 | 34 | 477007 | 1 | 1 |
| 2023-10-03 | 4 | 4 | 0000950170-23-051615 | 5612 | ||||||
| 2023-10-03 | 4 | 4 | 0000950170-23-051604 | 5598 | ||||||
| 2023-08-08 | S-8 | S-8 | 0001193125-23-206264 | 333-273802 | 231151925 | 33 | 63092 | |||
| 2023-08-08 | 10-Q | 10-Q | 0000950170-23-039394 | 001-38443 | 231149465 | 34 | 7091526 | 1 | 1 | |
| 2023-08-08 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-039389 | 001-38443 | 231149450 | 34 | 494027 | 1 | 1 |
| 2023-07-05 | 4 | 4 | 0000950170-23-031704 | 5598 | ||||||
| 2023-07-05 | 4 | 4 | 0000950170-23-031702 | 5609 | ||||||
| 2023-06-13 | 4 | OWNERSHIP DOCUMENT | 0001104659-23-070794 | 10392 | ||||||
| 2023-06-13 | SC 13D/A | SC 13D/A | 0001104659-23-070793 | 005-90431 | 231011304 | 34 | 63459 | |||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0000899243-23-014905 | 5539 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0000899243-23-014903 | 6121 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0000899243-23-014900 | 5528 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0000899243-23-014895 | 5547 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0000899243-23-014890 | 5539 | ||||||
| 2023-06-08 | 4 | FORM 4 SUBMISSION | 0000899243-23-014883 | 6117 | ||||||
| 2023-06-08 | 8-K | 8-K | 1.01,9.01 | 0001193125-23-163546 | 001-38443 | 231002356 | 34 | 416109 | 1 | 1 |
| 2023-06-08 | 424B5 | 424B5 | 0001193125-23-163485 | 333-269707 | 231001863 | 33 | 747245 | |||
| 2023-06-07 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-23-162557 | 001-38443 | 23999299 | 34 | 254739 | 1 | 1 |
| 2023-06-06 | 424B5 | 424B5 | 0001193125-23-161747 | 333-269707 | 23997049 | 33 | 720383 | |||
| 2023-06-06 | 8-K | 8-K | 8.01 | 0001193125-23-161596 | 001-38443 | 23996056 | 34 | 157268 | 1 | 1 |
| 2023-06-01 | SC 13G | COGENT BIOSCIENCES, INC. | 0000902664-23-003363 | 005-90431 | 23985489 | 34 | 72044 | |||
| 2023-05-09 | 10-Q | 10-Q | 0000950170-23-019166 | 001-38443 | 23900102 | 34 | 5691457 | 1 | 1 | |
| 2023-05-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-019162 | 001-38443 | 23900086 | 34 | 454902 | 1 | 1 |
| 2023-04-25 | ARS | ARS | 0001193125-23-115309 | 001-38443 | 23844969 | 34 | 13666620 | |||
| 2023-04-25 | DEFA14A | DEFA14A | 0001193125-23-115292 | 001-38443 | 23844910 | 34 | 466641 | |||
| 2023-04-25 | DEF 14A | DEF 14A | 0001193125-23-115281 | 001-38443 | 23844803 | 34 | 547017 | |||
| 2023-04-04 | 4 | FORM 4 SUBMISSION | 0000899243-23-010395 | 5828 | ||||||
| 2023-04-04 | 4 | FORM 4 SUBMISSION | 0000899243-23-010391 | 5839 | ||||||
| 2023-03-14 | S-8 | S-8 | 0001193125-23-070121 | 333-270522 | 23730672 | 33 | 83518 | |||
| 2023-03-14 | 10-K | 10-K | 0000950170-23-007729 | 001-38443 | 23729337 | 34 | 14921292 | 1 | 1 | |
| 2023-03-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-23-007717 | 001-38443 | 23729249 | 34 | 496657 | 1 | 1 |
| 2023-02-15 | 4 | FORM 4 SUBMISSION | 0000899243-23-005141 | 9590 | ||||||
| 2023-02-15 | 4 | FORM 4 SUBMISSION | 0000899243-23-005140 | 5466 | ||||||
| 2023-02-15 | 4 | FORM 4 SUBMISSION | 0000899243-23-005138 | 9554 | ||||||
| 2023-02-15 | 4 | FORM 4 SUBMISSION | 0000899243-23-005137 | 9567 | ||||||
| 2023-02-15 | 4 | FORM 4 SUBMISSION | 0000899243-23-005135 | 9607 | ||||||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021868 | 005-90431 | 23631002 | 34 | 265111 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-021816 | 005-90431 | 23630725 | 34 | 79029 | |||
| 2023-02-14 | SC 13G/A | formsc13ga.htm | 0001493152-23-004815 | 005-90431 | 23628780 | 34 | 91594 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 2 | 0001214659-23-002279 | 005-90431 | 23627109 | 34 | 81860 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001580642-23-000867 | 005-90431 | 23626684 | 34 | 58258 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001193125-23-038128 | 005-90431 | 23625420 | 34 | 222286 | |||
| 2023-02-14 | SC 13G/A | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 0000921895-23-000533 | 005-90431 | 23625113 | 34 | 277027 | |||
| 2023-02-10 | S-3ASR | S-3ASR | 0001193125-23-032798 | 333-269707 | 23613090 | 33 | 540671 | |||
| 2023-02-10 | SC 13G/A | e618238_sc13ga-cbi.htm | 0001193805-23-000130 | 005-90431 | 23608931 | 34 | 99723 | |||
| 2023-02-09 | SC 13G/A | JHG PLC OWNS <5% | 0001274173-23-000008 | 005-90431 | 23601642 | 34 | 10245 | |||
| 2023-02-03 | SC 13G | Cogent_Biosciences_Inc.txt | 0000093751-23-000162 | 005-90431 | 23585271 | 34 | 8573 | |||
| 2023-02-03 | SC 13G | us19240q2012_020323.txt | 0001306550-23-007060 | 005-90431 | 23584735 | 34 | 13359 | |||
| 2023-01-04 | 4 | FORM 4 SUBMISSION | 0000899243-23-000619 | 5809 | ||||||
| 2023-01-04 | 4 | FORM 4 SUBMISSION | 0000899243-23-000615 | 5798 | ||||||
| 2022-12-12 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-302302 | 001-38443 | 221456193 | 34 | 9485731 | 1 | 1 |
| 2022-11-14 | 10-Q | 10-Q | 0000950170-22-024685 | 001-38443 | 221380222 | 34 | 7911244 | 1 | 1 | |
| 2022-11-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-024675 | 001-38443 | 221380160 | 34 | 535487 | 1 | 1 |
| 2022-10-04 | 4 | FORM 4 SUBMISSION | 0000899243-22-032672 | 5842 | ||||||
| 2022-10-04 | 4 | FORM 4 SUBMISSION | 0000899243-22-032661 | 5831 | ||||||
| 2022-09-06 | SC 13G | SC 13G | 0001104659-22-097869 | 005-90431 | 221228607 | 34 | 75425 | |||
| 2022-08-09 | 10-Q | 10-Q | 0000950170-22-015760 | 001-38443 | 221146420 | 34 | 6754864 | 1 | 1 | |
| 2022-08-09 | 8-K | 8-K | 2.02,9.01 | 0000950170-22-015744 | 001-38443 | 221146375 | 34 | 489768 | 1 | 1 |
| 2022-07-08 | SC 13G | us19240q2012_070822.txt | 0000834237-22-010347 | 005-90431 | 221075093 | 34 | 12497 | |||
| 2022-07-05 | 4 | FORM 4 SUBMISSION | 0000899243-22-024930 | 5831 | ||||||
| 2022-07-05 | 4 | FORM 4 SUBMISSION | 0000899243-22-024929 | 5842 | ||||||
| 2022-07-01 | 4 | FORM 4 SUBMISSION | 0000899243-22-024711 | 5023 | ||||||
| 2022-06-21 | SC 13D/A | SC 13D/A | 0001104659-22-072800 | 005-90431 | 221026420 | 34 | 78117 | |||
| 2022-06-21 | 4 | OWNERSHIP DOCUMENT | 0001104659-22-072798 | 10335 | ||||||
| 2022-06-17 | SC 13G | e621751_sc13g-cbi.htm | 0001193805-22-000956 | 005-90431 | 221022412 | 34 | 97452 | |||
| 2022-06-16 | 8-K/A | 8-K/A | 1.01,8.01,9.01 | 0001193125-22-175601 | 001-38443 | 221021350 | 34 | 509913 | 1 | 1 |
| 2022-06-15 | 8-K | 8-K | 1.01,9.01 | 0001193125-22-174885 | 001-38443 | 221018576 | 34 | 512320 | 1 | 1 |
| 2022-06-15 | 424B5 | 424B5 | 0001193125-22-174881 | 333-264773 | 221018556 | 33 | 578981 | |||
| 2022-06-14 | FWP | FWP | 0001193125-22-173230 | 333-264773 | 221013337 | 34 | 37413 | |||
| 2022-06-13 | 424B5 | 424B5 | 0001193125-22-172369 | 333-264773 | 221010658 | 33 | 568876 | |||
| 2022-06-10 | 8-K | 8-K | 5.07,8.01,9.01 | 0001193125-22-171489 | 001-38443 | 221007623 | 34 | 10273283 | 1 | 1 |
| 2022-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-22-021648 | 5678 | ||||||
| 2022-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-22-021646 | 9531 | ||||||
| 2022-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-22-021645 | 5689 | ||||||
| 2022-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-22-021643 | 10023 | ||||||
| 2022-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-22-021639 | 10023 | ||||||
| 2022-06-09 | 4 | FORM 4 SUBMISSION | 0000899243-22-021636 | 9528 | ||||||
| 2022-05-24 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2022-05-24 16:00:00 | 9999999995-22-001579 | 333-264773 | 22958810 | 33 | 1926 | ||
| 2022-05-20 | CORRESP | filename1.htm | 0001193125-22-156292 | 6457 | ||||||
| 2022-05-17 | UPLOAD | filename1.pdf | 0000000000-22-005363 | 40427 | ||||||
| 2022-05-13 | EFFECT | xslEFFECTX01/primary_doc.xml | POS AM,0001193125-22-143704,2022-05-13 | 9999999995-22-001452 | 333-252873 | 22925114 | 33 | 1939 | ||
| 2022-05-10 | 10-Q | 10-Q | 0001564590-22-019089 | 001-38443 | 22907499 | 34 | 5250104 | 1 | 1 | |
| 2022-05-10 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-019075 | 001-38443 | 22907374 | 34 | 406328 | 1 | 1 |
| 2022-05-06 | S-3 | S-3 | 0001193125-22-143829 | 333-264773 | 22902489 | 33 | 853045 | |||
| 2022-05-06 | POS AM | POS AM | 0001193125-22-143704 | 333-252873 | 22901776 | 33 | 20392 | |||
| 2022-05-06 | 8-K | 8-K | 1.02 | 0001193125-22-143689 | 001-38443 | 22901482 | 34 | 149172 | 1 | 1 |
| 2022-04-26 | DEFA14A | DEFA14A | 0001193125-22-118978 | 001-38443 | 22851880 | 34 | 680223 | |||
| 2022-04-26 | DEF 14A | DEF 14A | 0001193125-22-118969 | 001-38443 | 22851874 | 34 | 805929 | |||
| 2022-04-05 | 4 | FORM 4 SUBMISSION | 0000899243-22-013710 | 9805 | ||||||
| 2022-04-05 | 4 | FORM 4 SUBMISSION | 0000899243-22-013702 | 9816 | ||||||
| 2022-03-17 | S-8 | S-8 | 0001193125-22-078297 | 333-263638 | 22748530 | 33 | 92596 | |||
| 2022-03-15 | 10-K | 10-K | 0001564590-22-010238 | 001-38443 | 22739258 | 34 | 10709128 | 1 | 1 | |
| 2022-03-15 | 8-K | 8-K | 2.02,9.01 | 0001564590-22-010231 | 001-38443 | 22739175 | 34 | 486557 | 1 | 1 |
| 2022-03-01 | SC 13G | SC 13G | 0001193125-22-061021 | 005-90431 | 22696933 | 34 | 152981 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001104659-22-022823 | 005-90431 | 22632088 | 34 | 181893 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001104659-22-022819 | 005-90431 | 22632072 | 34 | 82710 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0000905718-22-000320 | 005-90431 | 22631637 | 34 | 52972 | |||
| 2022-02-14 | SC 13G/A | cogent13ga3.htm | 0000935836-22-000144 | 005-90431 | 22629299 | 34 | 75148 | |||
| 2022-02-14 | SC 13G | THE SCHEDULE 13G | 0000921895-22-000531 | 005-90431 | 22628945 | 34 | 289134 | |||
| 2022-02-14 | SC 13G | SC 13G | 0001580642-22-000820 | 005-90431 | 22627378 | 34 | 61739 | |||
| 2022-02-11 | SC 13G/A | SC 13G/A | 0001193125-22-037084 | 005-90431 | 22621228 | 34 | 123483 | |||
| 2022-02-11 | SC 13G | JANUS HENDERSON GROUP PLC OWNS >5% | 0001274173-22-000069 | 005-90431 | 22619039 | 34 | 10757 | |||
| 2022-02-04 | SC 13G | us19240q2012_020422.txt | 0000834237-22-007223 | 005-90431 | 22593533 | 34 | 13381 | |||
| 2022-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-22-003475 | 5559 | ||||||
| 2022-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-22-003474 | 5545 | ||||||
| 2022-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-22-003469 | 5513 | ||||||
| 2022-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-22-003465 | 5576 | ||||||
| 2022-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-22-003462 | 5590 | ||||||
| 2022-01-25 | SC 13G/A | SCHEDULE 13G/A | 0001104659-22-007253 | 005-90431 | 22551901 | 34 | 92872 | |||
| 2022-01-04 | 4 | FORM 4 SUBMISSION | 0000899243-22-000694 | 5019 | ||||||
| 2022-01-04 | 4 | FORM 4 SUBMISSION | 0000899243-22-000693 | 5903 | ||||||
| 2022-01-04 | 4 | FORM 4 SUBMISSION | 0000899243-22-000691 | 5914 | ||||||
| 2021-12-27 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-367000 | 001-38443 | 211520409 | 34 | 312597 | 1 | 1 |
| 2021-11-17 | SC 13G/A | AMENDMENT NO. 1 | 0001214659-21-011957 | 005-90431 | 211420488 | 34 | 41998 | |||
| 2021-11-10 | 10-Q | 10-Q | 0001564590-21-055947 | 001-38443 | 211394531 | 34 | 6294884 | 1 | 1 | |
| 2021-11-10 | 8-K | 8-K | 2.02,9.01 | 0001564590-21-055942 | 001-38443 | 211394508 | 34 | 399368 | 1 | 1 |
| 2021-11-04 | SC 13G | SC 13G | 0000905718-21-001428 | 005-90431 | 211376772 | 34 | 55552 | |||
| 2021-10-05 | 4 | FORM 4 SUBMISSION | 0000899243-21-039329 | 5905 | ||||||
| 2021-10-05 | 4 | FORM 4 SUBMISSION | 0000899243-21-039303 | 5916 | ||||||
| 2021-08-17 | S-8 | S-8 | 0001193125-21-248036 | 333-258865 | 211180213 | 33 | 52808 | |||
| 2021-08-16 | 10-Q | 10-Q | 0001564590-21-044445 | 001-38443 | 211174496 | 34 | 5819796 | 1 | 1 | |
| 2021-08-16 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-246896 | 001-38443 | 211174473 | 34 | 221537 | 1 | 1 |
| 2021-07-09 | 8-K | 8-K | 1.01,9.01 | 0001193125-21-211800 | 001-38443 | 211082860 | 34 | 405470 | ||
| 2021-07-08 | SC 13G | d78214sc13g.htm | 0001214659-21-007370 | 005-90431 | 211079839 | 34 | 41854 | |||
| 2021-07-06 | 4 | FORM 4 SUBMISSION | 0000899243-21-027628 | 5916 | ||||||
| 2021-07-06 | 4 | FORM 4 SUBMISSION | 0000899243-21-027625 | 5905 | ||||||
| 2021-06-17 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-21-192654 | 001-38443 | 211023345 | 34 | 102214 | ||
| 2021-05-12 | 10-Q | 10-Q | 0001564590-21-026737 | 001-38443 | 21913472 | 34 | 4669496 | 1 | ||
| 2021-05-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-158322 | 001-38443 | 21913435 | 34 | 70388 | ||
| 2021-05-05 | 4 | FORM 4 SUBMISSION | 0000899243-21-018362 | 5645 | ||||||
| 2021-05-05 | 3 | FORM 3 SUBMISSION | 0000899243-21-018359 | 7208 | ||||||
| 2021-04-30 | DEFA14A | DEFA14A | 0001193125-21-145002 | 001-38443 | 21877889 | 34 | 341040 | |||
| 2021-04-30 | DEF 14A | DEF 14A | 0001193125-21-144950 | 001-38443 | 21877713 | 34 | 776650 | |||
| 2021-04-28 | 4 | FORM 4 SUBMISSION | 0000899243-21-017261 | 5502 | ||||||
| 2021-04-15 | 3 | FORM 3 SUBMISSION | 0000899243-21-015905 | 8568 | ||||||
| 2021-04-05 | 4 | FORM 4 SUBMISSION | 0000899243-21-014969 | 5904 | ||||||
| 2021-04-05 | 4 | FORM 4 SUBMISSION | 0000899243-21-014967 | 5915 | ||||||
| 2021-03-31 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-001037 | 273010 | ||||||
| 2021-03-18 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2021-03-18 17:00:00 | 9999999995-21-000998 | 333-252873 | 21756411 | 33 | 1926 | ||
| 2021-03-16 | CORRESP | filename1.htm | 0001193125-21-082984 | 6856 | ||||||
| 2021-03-16 | S-8 | S-8 | 0001193125-21-082174 | 333-254320 | 21743678 | 33 | 72656 | |||
| 2021-03-16 | 10-K | 10-K | 0001564590-21-013325 | 001-38443 | 21743647 | 34 | 11382178 | 1 | ||
| 2021-03-16 | 8-K | 8-K | 2.02 | 0001193125-21-082091 | 001-38443 | 21743613 | 34 | 83680 | ||
| 2021-03-15 | 4 | FORM 4 SUBMISSION | 0000899243-21-011730 | 9483 | ||||||
| 2021-03-15 | 4 | FORM 4 SUBMISSION | 0000899243-21-011698 | 5451 | ||||||
| 2021-03-15 | 4 | FORM 4 SUBMISSION | 0000899243-21-011695 | 5470 | ||||||
| 2021-03-15 | 4 | FORM 4 SUBMISSION | 0000899243-21-011694 | 5462 | ||||||
| 2021-03-15 | 4 | FORM 4 SUBMISSION | 0000899243-21-011693 | 9477 | ||||||
| 2021-03-15 | 4 | FORM 4 SUBMISSION | 0000899243-21-011688 | 9479 | ||||||
| 2021-03-03 | SEC STAFF LETTER | filename1.pdf | 9999999997-21-000710 | 278027 | ||||||
| 2021-03-01 | 4 | FORM 4 SUBMISSION | 0000899243-21-008812 | 5090 | ||||||
| 2021-02-24 | 4 | FORM 4 SUBMISSION | 0000899243-21-008077 | 5470 | ||||||
| 2021-02-24 | 3 | FORM 3 SUBMISSION | 0000899243-21-008076 | 7303 | ||||||
| 2021-02-22 | 8-K | 8-K | 5.02 | 0001193125-21-050875 | 001-38443 | 21661093 | 34 | 19482 | ||
| 2021-02-16 | SC 13G/A | SCHEDULE 13G/A | 0001104659-21-024053 | 005-90431 | 21638807 | 34 | 79706 | |||
| 2021-02-16 | SC 13G/A | cogent13ga.htm | 0000935836-21-000173 | 005-90431 | 21637011 | 34 | 78716 | |||
| 2021-02-12 | 4 | FORM 4 SUBMISSION | 0000899243-21-006403 | 5589 | ||||||
| 2021-02-12 | 4 | FORM 4 SUBMISSION | 0000899243-21-006402 | 7989 | ||||||
| 2021-02-12 | 4 | FORM 4 SUBMISSION | 0000899243-21-006400 | 5544 | ||||||
| 2021-02-12 | SC 13G/A | SC 13G/A | 0001193125-21-041532 | 005-90431 | 21627572 | 34 | 136802 | |||
| 2021-02-12 | UPLOAD | filename1.pdf | 0000000000-21-001830 | 40429 | ||||||
| 2021-02-12 | SC 13G/A | formsc13ga.htm | 0001493152-21-003537 | 005-90431 | 21623606 | 34 | 185849 | |||
| 2021-02-11 | SC 13G/A | AMENDMENT NO. 1 TO THE SCHEDULE 13G | 0000921895-21-000327 | 005-90431 | 21620510 | 34 | 283376 | |||
| 2021-02-09 | S-3 | S-3 | 0001193125-21-032929 | 333-252873 | 21603716 | 33 | 821304 | |||
| 2021-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-004384 | 9779 | ||||||
| 2021-02-02 | SC 13G/A | SC 13G/A | 0001104659-21-010771 | 005-90431 | 21580007 | 34 | 119707 | |||
| 2021-01-06 | 4 | FORM 4 SUBMISSION | 0000899243-21-000793 | 9941 | ||||||
| 2021-01-06 | 4 | FORM 4 SUBMISSION | 0000899243-21-000792 | 9940 | ||||||
| 2020-12-09 | 4 | FORM 4 SUBMISSION | 0000899243-20-033232 | 9760 | ||||||
| 2020-12-07 | 4 | FORM 4 SUBMISSION | 0000899243-20-032853 | 9215 | ||||||
| 2020-12-03 | SC 13G | sc13g.htm | 0001493152-20-022880 | 005-90431 | 201365873 | 34 | 192927 | |||
| 2020-12-02 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-20-308501 | 001-38443 | 201364642 | 34 | 234845 | ||
| 2020-12-02 | 424B5 | 424B5 | 0001193125-20-308495 | 333-230678 | 201364613 | 33 | 923569 | |||
| 2020-12-02 | 424B3 | 424B3 | 0001193125-20-307560 | 333-230678 | 201362205 | 33 | 51167 | |||
| 2020-11-30 | 424B5 | 424B5 | 0001193125-20-305790 | 333-230678 | 201359096 | 33 | 926497 | |||
| 2020-11-30 | 8-K | 8-K | 8.01,9.01 | 0001193125-20-305716 | 001-38443 | 201358853 | 34 | 7056939 | ||
| 2020-11-19 | SC 13G/A | cogt13ga.htm | 0000935836-20-000653 | 005-90431 | 201328875 | 34 | 86074 | |||
| 2020-11-19 | SC 13G | c11182020sc13g.htm | 0001214659-20-009754 | 005-90431 | 201328307 | 34 | 137294 | |||
| 2020-11-09 | 10-Q | 10-Q | 0001564590-20-052593 | 001-38443 | 201298714 | 34 | 7551229 | 1 | ||
| 2020-11-09 | 8-K | 8-K | 2.02,3.03,5.03,5.07,9.01 | 0001193125-20-288493 | 001-38443 | 201296108 | 34 | 128308 | ||
| 2020-11-05 | S-8 | S-8 | 0001193125-20-286975 | 333-249884 | 201291422 | 33 | 74577 | |||
| 2020-10-27 | 4 | FORM 4 SUBMISSION | 0001209191-20-055909 | 5657 | ||||||
| 2020-10-27 | 3 | FORM 3 SUBMISSION | 0001209191-20-055908 | 6615 | ||||||
| 2020-10-26 | 8-K | 8-K | 5.02,7.01,9.01 | 0001193125-20-276049 | 001-38443 | 201259019 | 34 | 187355 | ||
| 2020-10-23 | 8-K | 8-K | 5.02,9.01 | 0001193125-20-275468 | 001-38443 | 201257864 | 34 | 29278 | ||
| 2020-10-15 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2020-10-15 16:01:00 | 9999999995-20-002858 | 333-248971 | 201242685 | 33 | 1927 | ||
| 2020-10-15 | 4 | FORM 4 SUBMISSION | 0001209191-20-054904 | 5622 | ||||||
| 2020-10-13 | UPLOAD | filename1.pdf | 0000000000-20-009654 | 40037 | ||||||
| 2020-10-13 | CORRESP | filename1.htm | 0001193125-20-268507 | 6638 | ||||||
| 2020-10-09 | DEFM14A | DEFM14A | 0001193125-20-267267 | 001-38443 | 201233693 | 34 | 1647071 | |||
| 2020-10-08 | 4 | FORM 4 SUBMISSION | 0001209191-20-054312 | 42689 | ||||||
| 2020-10-06 | CORRESP | filename1.htm | 0001193125-20-264862 | 19221 | ||||||
| 2020-10-06 | PRER14A | PRER14A | 0001193125-20-264858 | 001-38443 | 201227622 | 34 | 1702895 | |||
| 2020-10-06 | 10-Q/A | 10-Q/A | 0001193125-20-264799 | 001-38443 | 201227185 | 34 | 326881 | |||
| 2020-10-06 | UPLOAD | filename1.pdf | 0000000000-20-009384 | 45142 | ||||||
| 2020-10-05 | 8-K | 8-K | 5.03,7.01,9.01 | 0001193125-20-263412 | 001-38443 | 201222446 | 34 | 8976240 | ||
| 2020-10-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-053277 | 5806 | ||||||
| 2020-10-02 | 4 | FORM 4 SUBMISSION | 0001209191-20-053276 | 5805 | ||||||
| 2020-10-02 | CORRESP | filename1.htm | 0001193125-20-262532 | 23628 | ||||||
| 2020-10-02 | PRER14A | PRER14A | 0001193125-20-262526 | 001-38443 | 201220292 | 34 | 1859680 | |||
| 2020-09-30 | UPLOAD | filename1.pdf | 0000000000-20-009214 | 46730 | ||||||
| 2020-09-22 | S-3 | S-3 | 0001193125-20-251424 | 333-248971 | 201190269 | 33 | 654148 | |||
| 2020-09-22 | CORRESP | filename1.htm | 0001193125-20-251278 | 24264 |
One latest value per concept from companyfacts (304 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 173.99M | 2026-11-03 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 772.90M | 2025-06-30 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| ecd | CoSelectedMeasureAmt | CoSelectedMeasureAmt | USD | 35.52 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001193125-26-173834 | ||
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 40.52M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001193125-26-173834 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 8.93M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001193125-26-173834 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 120.69 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001193125-26-173834 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 116.77M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001193125-26-173834 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 27.76M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001193125-26-173834 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 413.99 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-23 | 0001193125-26-173834 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 55,240 | 2026-08-08 | 424B5 | 2026-08-10 | 0001193125-26-342683 | |||
| ffd | NrrtvMaxAggtOfferingPric | NrrtvMaxAggtOfferingPric | USD | 400.00M | 2026-08-08 | 424B5 | 2026-08-10 | 0001193125-26-342683 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 55,240 | 2026-08-08 | 424B5 | 2026-08-10 | 0001193125-26-342683 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 400.00M | 2026-08-08 | 424B5 | 2026-08-10 | 0001193125-26-342683 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-08-08 | 424B5 | 2026-08-10 | 0001193125-26-342683 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-08-08 | 424B5 | 2026-08-10 | 0001193125-26-342683 | |||
| us-gaap | AccountsPayableAndAccruedLiabilitiesCurrent | Accounts Payable and Accrued Liabilities, Current | USD | 2.75M | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-12 | 0001564590-21-026737 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 5.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 2.00M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013325 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 2.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 400,000 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 8.68M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -717,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 1.95B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Decrease for Tax Withholding Obligation | USD | 48.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 16.87M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 50.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | AmortizationOfFinancingCostsAndDiscounts | Amortization of Debt Issuance Costs and Discounts | USD | 849,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 36.97M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | AreaOfRealEstateProperty | Area of Real Estate Property | sqft | 5,000 | 2017-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | Assets | Assets | USD | 832.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 803.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 487,000 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-11 | 0001564590-20-039357 | |
| us-gaap | AssetsFairValueDisclosureRecurring | Assets, Fair Value Disclosure, Recurring (Deprecated 2018-01-31) | USD | 28.99M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-14 | 0001193125-18-161541 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 363,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 7,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 588.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042995 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 0 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042995 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 0 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042995 | |
| us-gaap | AvailableForSaleSecuritiesCurrent | Available-for-sale Securities, Current | USD | 22.92M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 588.75M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 573.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 7.46M | 2023-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026115 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 81,000 | 2018-01-01 | 2018-06-30 | 2019 | Q2 | 10-Q | 2019-08-12 | 0001564590-19-031485 |
| us-gaap | CapitalizedContractCostNet | Capitalized Contract Cost, Net | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013325 | |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 217.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 217.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | 18.44M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-13 | 0001193125-18-247281 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | -94.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0.01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 3.03M | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-09 | 0000950170-22-015760 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 300.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 173.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 173.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 174,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -306.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 15.20M | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-12 | 0001564590-19-031485 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 1.31M | 2019-12-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013325 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 8.71M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | ContractWithCustomerLiabilityRevenueRecognized | Contract with Customer, Liability, Revenue Recognized | USD | 7.20M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-11-12 | 0001564590-19-042995 |
| us-gaap | ConvertibleDebtNoncurrent | Convertible Debt, Noncurrent | USD | 223.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | ConvertiblePreferredStockConvertedToOtherSecurities | Convertible Preferred Stock Converted to Other Securities | USD | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-053977 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 13.23M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 323.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | DebtInstrumentCarryingAmount | Long-term Debt, Gross | USD | 230.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net | USD | 6.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostCurrent | Debt Securities, Available-for-sale, Amortized Cost, Current | USD | 59.55M | 2023-03-31 | 2023 | Q1 | 10-Q | 2023-05-09 | 0000950170-23-019166 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 513.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions | Debt Securities, Available-for-sale, Unrealized Loss Position, Number of Positions | Security | 10 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | DeferredCosts | Deferred Costs, Noncurrent | USD | 1.37M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | DeferredRentCreditNoncurrent | Deferred Rent Credit, Noncurrent | USD | 748,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 | |
| us-gaap | DeferredRevenue | Deferred Revenue | USD | 15.61M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | DeferredRevenueCurrent | Deferred Revenue, Current | USD | 17.95M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | DeferredRevenueNoncurrent | Deferred Revenue, Noncurrent | USD | 8.71M | 2017-12-31 | 2018 | Q3 | 10-Q | 2018-11-13 | 0001193125-18-324954 | |
| us-gaap | DeferredRevenueRevenueRecognized1 | Deferred Revenue, Revenue Recognized | USD | 5.90M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-13 | 0001193125-18-324954 |
| us-gaap | DeferredTaxAssetsDeferredIncome | Deferred Tax Assets, Deferred Income | USD | 3.29M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 28.90M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 100.59M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 425.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 2.43M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwards | Deferred Tax Assets, Tax Credit Carryforwards | USD | 70.59M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 10.88M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 3.64M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsContingencies | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Contingencies | USD | 338,000 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026115 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 311.03M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 2.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | DefinedContributionPlanEmployersMatchingContributionAnnualVestingPercentage | Defined Contribution Plan, Employers Matching Contribution, Annual Vesting Percentage | pure | 0.04 | 2021-01-01 | 2021-03-31 | 2021 | Q1 | 10-Q | 2021-05-12 | 0001564590-21-026737 |
| us-gaap | Depreciation | Depreciation | USD | 2.56M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 1.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | DividendsCommonStock | Dividends, Common Stock | USD | 11.45M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0001564590-22-010238 |
| us-gaap | DividendsPayableCurrentAndNoncurrent | Dividends Payable | USD | 0 | 2018-09-30 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | DividendsPreferredStock | Dividends, Preferred Stock | USD | 104.40M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013325 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.65 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.68 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001564590-22-019089 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -1.65 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.268 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate | Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent | pure | 0.044 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | -0.013 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013325 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseDepreciationAndAmortization | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Depreciation and Amortization, Percent | pure | -0.123 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0001564590-22-010238 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | 0.061 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | -0.009 | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.079 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026115 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | 0.028 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 15.17M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | EmployeeServiceShareBasedCompensationCashFlowEffectCashUsedToSettleAwards | Share-based Payment Arrangement, Cash Used to Settle Award | USD | 48.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions | Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount | USD | 8.60M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | FinancialLiabilitiesFairValueDisclosure | Financial Liabilities Fair Value Disclosure | USD | 0 | 2021-06-30 | 2021 | Q2 | 10-Q | 2021-08-16 | 0001564590-21-044445 | |
| us-gaap | GainLossOnDispositionOfAssets | Gain (Loss) on Disposition of Property Plant Equipment, Excluding Oil and Gas Property and Timber Property | USD | 78,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -134,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -7.18M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 102.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | ImpairmentOfLongLivedAssetsHeldForUse | Impairment of Long-Lived Assets Held-for-use | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0001564590-22-010238 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount | USD | 88.13M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -69.08M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 53,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | -20.09M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 9.05M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | -3.56M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | -2.00M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0001564590-22-010238 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 12.70M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | -1.31M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0001564590-22-010238 |
| us-gaap | IncreaseDecreaseInDeferredLiabilities | Increase (Decrease) in Deferred Liabilities | USD | -52,000 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 |
| us-gaap | IncreaseDecreaseInDeferredRevenue | Increase (Decrease) in Deferred Revenue | USD | -1.71M | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-13 | 0001193125-18-324954 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | -1.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | 90,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 2.86M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 3.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 1.84M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 22.12M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | InvestmentTaxCredit | Investment Tax Credit | USD | 200,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 1.80M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 |
| us-gaap | LeaseCost | Lease, Cost | USD | 221,000 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001564590-22-019089 |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.083 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 30.12M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 14.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 2.95M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 3.39M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 3.31M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 3.23M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 3.15M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 2.51M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-14 | 0000950170-22-024685 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 14.21M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | Liabilities | Liabilities | USD | 315.88M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 832.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 73.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | LongTermDebt | Long-term Debt | USD | 223.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | LongTermDebtFairValue | Long-term Debt, Fair Value | USD | 248.40M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-07 | 0001193125-25-272334 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 14.58M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-07 | 0001193125-25-272334 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-07 | 0001193125-25-272334 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-07 | 0001193125-25-272334 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear | Long-Term Debt, Maturity, Remainder of Fiscal Year | USD | 0 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-07 | 0001193125-25-272334 | |
| us-gaap | LongTermDebtNoncurrent | Long-term Debt, Excluding Current Maturities | USD | 44.25M | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-07 | 0001193125-25-272334 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 6.70M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-14 | 0001193125-18-161541 | |
| us-gaap | MarketableSecuritiesRealizedGainLoss | Marketable Securities, Realized Gain (Loss) | USD | -2,000 | 2019-01-01 | 2019-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001564590-20-052593 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 135.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | -535,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-14 | 0001193125-18-161541 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 15.13M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | 5.92M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-14 | 0001193125-18-161541 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -244.94M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | -7.98M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-14 | 0001193125-18-161541 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -305.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -187.93M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-12 | 0000950170-24-124712 |
| us-gaap | NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1 | New Accounting Pronouncement or Change in Accounting Principle, Cumulative Effect of Change on Equity or Net Assets (Deprecated 2020-01-31) | USD | -6.19M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 | |
| us-gaap | NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfChangeOnNetIncome | New Accounting Pronouncement or Change in Accounting Principle, Effect of Change on Net Income (Deprecated 2020-01-31) | USD | -6.19M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 18.25M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -323.43M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 3.29M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026115 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 15.90M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 1.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 18.90M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 2.84M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 21.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 1.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 8.54M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 1.88M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 689,000 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 2.05M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 1.99M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 1.93M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 689,000 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-13 | 0001193125-18-324954 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 1.88M | 2019-03-31 | 2019 | Q1 | 10-Q | 2019-05-13 | 0001193125-19-144768 | |
| us-gaap | OperatingLeasesRentExpenseSubleaseRentals1 | Operating Leases, Rent Expense, Sublease Rentals | USD | 300,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.063 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 2.34M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 1.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -285,000 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-053977 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -1.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment and Tax | USD | 53,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, after Tax | USD | -1.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax | OCI, Debt Securities, Available-for-Sale, Unrealized Holding Gain (Loss), before Adjustment, Tax | USD | 0 | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013325 |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 123,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | OtherNonoperatingIncome | Other Nonoperating Income | USD | 1.99M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026115 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -202,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | PaidInKindInterest | Paid-in-Kind Interest | USD | 23,000 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 4.17M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013325 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 11.60M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-07 | 0000950170-24-053977 |
| us-gaap | PaymentsRelatedToTaxWithholdingForShareBasedCompensation | Payment, Tax Withholding, Share-based Payment Arrangement | USD | 48.90M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 290.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 927,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | PreferredStockAccretionOfRedemptionDiscount | Preferred Stock, Accretion of Redemption Discount | USD | 16,000 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 |
| us-gaap | PreferredStockDividendsIncomeStatementImpact | Preferred Stock Dividends, Income Statement Impact | USD | 104.40M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0001564590-22-010238 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0.001 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 12.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | ProceedsFromDivestitureOfBusinesses | Proceeds from Divestiture of Businesses | USD | 8.10M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0001564590-22-010238 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026115 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockAndPreferenceStock | Proceeds from Issuance of Preferred Stock and Preference Stock | USD | 98.91M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0001564590-22-010238 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 213.30M | 2024-02-01 | 2024-02-29 | 2025 | Q3 | 10-Q | 2025-11-07 | 0001193125-25-272334 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | USD | 2.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 306.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 320,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0001564590-22-010238 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 15.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-25 | 0000950170-25-026115 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -305.18M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 14.14M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 4.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | PurchaseObligation | Purchase Obligation | USD | 108.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | RepaymentsOfDebt | Repayments of Debt | USD | 54.63M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 221.28M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 44.81M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0001564590-22-010238 |
| us-gaap | RestrictedCashCurrent | Restricted Cash, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-26 | 0000950170-24-019770 | |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 416,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | RestructuringAndRelatedCostExpectedNumberOfPositionsEliminated | Restructuring and Related Cost, Expected Number of Positions Eliminated | Employee | 43 | 2020-03-02 | 2021 | Q1 | 10-Q | 2021-05-12 | 0001564590-21-026737 | |
| us-gaap | RestructuringAndRelatedCostNumberOfPositionsEliminatedPeriodPercent | Restructuring and Related Cost, Number of Positions Eliminated, Period Percent | pure | 0.6 | 2020-03-02 | 2021 | Q1 | 10-Q | 2021-05-12 | 0001564590-21-026737 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 4.17M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013325 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 73,000 | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-09 | 0001564590-20-052593 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.49B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | RevenueFromContractWithCustomerIncludingAssessedTax | Revenue from Contract with Customer, Including Assessed Tax | USD | 7.87M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0001564590-22-010238 |
| us-gaap | RevenueRemainingPerformanceObligation | Revenue, Remaining Performance Obligation, Amount | USD | 71.30M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-13 | 0001193125-18-324954 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 5.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | SalesRevenueServicesNet | Sales Revenue, Services, Net (Deprecated 2018-01-31) | USD | 2.22M | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-05-14 | 0001193125-18-161541 |
| us-gaap | SeveranceCosts1 | Severance Costs | USD | 4.20M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013325 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 50.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost | Share-based Payment Arrangement, Accelerated Cost | USD | 700,000 | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-07 | 0001193125-25-272334 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.854 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.043 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 4.87M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 2.09M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 2.89 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 28.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 198,936 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 929,231 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 9.52 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 5.02M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 3.66M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 5.92 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 5.92 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 5.02M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 3.66M | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 2.71 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 7.54 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 12 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 |
| us-gaap | SharePrice | Share Price | USD/shares | 8.8 | 2020-07-06 | 2023 | Q3 | 10-Q | 2023-11-07 | 0000950170-23-059769 | |
| us-gaap | SharesPaidForTaxWithholdingForShareBasedCompensation | Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation | shares | 1.24M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 516.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.637 | 2018-03-16 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-26 | 0000950170-24-019770 |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 225,252 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 77.17M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 1.28M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 260,000 | 2021-01-01 | 2021-12-31 | 2023 | FY | 10-K | 2024-02-26 | 0000950170-24-019770 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 71.80M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 5.29M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 950,000 | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | TaxCutsAndJobsActOf2017ChangeInTaxRateIncomeTaxExpenseBenefit | Tax Cuts and Jobs Act, Change in Tax Rate, Income Tax Expense (Benefit) | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 |
| us-gaap | TemporaryEquityAccretionToRedemptionValueAdjustment | Temporary Equity, Accretion to Redemption Value, Adjustment | USD | 16,000 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-26 | 0001564590-20-013188 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 77.15M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 77.30M | 2017-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | TemporaryEquityParOrStatedValuePerShare | Temporary Equity, Par or Stated Value Per Share | USD/shares | 0.001 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-03-28 | 0001193125-19-089299 | |
| us-gaap | TreasuryStockRetiredCostMethodAmount | Treasury Stock, Retired, Cost Method, Amount | USD | 808,000 | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0001564590-22-010238 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | ValuationAllowancesAndReservesBalance | SEC Schedule, 12-09, Valuation Allowances and Reserves, Amount | USD | 311.03M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 | |
| us-gaap | ValuationAllowancesAndReservesChargedToCostAndExpense | SEC Schedule, 12-09, Valuation Allowances and Reserves, Additions, Charge to Cost and Expense | USD | 92.48M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | ValuationAllowancesAndReservesDeductions | SEC Schedule, 12-09, Valuation Allowances and Reserves, Deduction | USD | 10.69M | 2020-01-01 | 2020-12-31 | 2021 | FY | 10-K | 2022-03-15 | 0001564590-22-010238 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 714,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-17 | 0001193125-26-053334 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 168.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 45.11M | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-10 | 0001564590-22-019089 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 168.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001193125-26-449963 |